Publicaciones en colaboración con investigadoras/es de Hospital Universitario Marqués de Valdecilla (11)

2008

  1. A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 5, pp. 625-630

2007

  1. Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas (BIOBADASER): Informe de la situación, 26 de enero de 2006

    Reumatologia Clinica, Vol. 3, Núm. 1, pp. 4-20

2006

  1. Switching TNF antagonists in patients with chronic arthritis: An observational study of 488 patients over a four-year period

    Arthritis Research and Therapy, Vol. 8, Núm. 1

2005

  1. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists

    Arthritis and Rheumatism, Vol. 52, Núm. 6, pp. 1766-1772

2000

  1. Giant cell arteritis with an erythrocyte sedimentation rate lower than 50

    Clinical Rheumatology, Vol. 19, Núm. 1, pp. 73-75

  2. Haematogenous vertebral osteomyelitis in the elderly

    Clinical Rheumatology, Vol. 19, Núm. 5, pp. 344-347

1999

  1. Vertebral osteomyelitis in northern Spain. Report of 62 cases

    Clinical and Experimental Rheumatology, Vol. 17, Núm. 4, pp. 447-452

1998

  1. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: Predictors and response to treatment

    Arthritis and Rheumatism, Vol. 41, Núm. 8, pp. 1497-1504

1997

  1. Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate: A more benign syndrome

    Archives of Internal Medicine, Vol. 157, Núm. 3, pp. 317-320

  2. Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica

    American Journal of Medicine, Vol. 102, Núm. 4, pp. 331-336

1995

  1. ARTERITIS DE CELULAS GIGANTES. ESTUDIO DE 191 PACIENTES

    Medicina Clinica, Vol. 105, Núm. 19, pp. 734-737